Skip to main content
Quest Diagnostics

Early Insights From a Pharmacogenomic-Enriched Comprehensive Medication Management Program Implementation in an Adult Employee Population

Precision Medicine Leaders Summit, 2023

Orlando, FL, March 2-3, 2023

Poster presentation: Early insights from a pharmacogenomic-enriched comprehensive medication management program implementation in an adult employee population

Authors: Keogh M, Fragala MS, Peter AP,  Lorenz RA, Goldberg SE, Shaman JA

Specialties: Genetics, Neurology, Prescription Drug Monitoring and Toxicology

Publication
Early insights from a pharmacogenomic-enriched comprehensive medication management program implementation in an adult employee population
Publication
Role of Pharmacogenomics in Comprehensive Medication Management: Considerations for Employers
On-Demand Webinar
Current state of Pharmacogenomics and its future

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.